A detailed history of Braidwell LP transactions in Xencor Inc stock. As of the latest transaction made, Braidwell LP holds 615,531 shares of XNCR stock, worth $8.9 Million. This represents 0.79% of its overall portfolio holdings.

Number of Shares
615,531
Previous 466,448 31.96%
Holding current value
$8.9 Million
Previous $9.38 Billion 99.85%
% of portfolio
0.79%
Previous 0.27%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

BUY
$19.43 - $26.84 $2.9 Million - $4 Million
149,083 Added 31.96%
615,531 $14.1 Million
Q3 2024

Nov 14, 2024

BUY
$15.7 - $21.65 $7.32 Million - $10.1 Million
466,448 New
466,448 $9.38 Billion

Others Institutions Holding XNCR

About Xencor Inc


  • Ticker XNCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,698,100
  • Market Cap $863M
  • Description
  • Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...
More about XNCR
Track This Portfolio

Track Braidwell LP Portfolio

Follow Braidwell LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Braidwell LP, based on Form 13F filings with the SEC.

News

Stay updated on Braidwell LP with notifications on news.